🚀💭Today’s questions! Swipe to see the answers and explanations! #XLEPP #EPP #Porphyria #ALAS2 #PPIX #Hematology #HemeOnc #MedEd #MedicalEducation #HemeHub

🩸Facts about Acute Hepatic Porphyria: ADP and its lack of response to givosiran, EPP and PPIX accumulation, light-induced phototoxic pain, limited response to standard analgesics, and the risk of severe liver complications. #Porphyria #AHP #EPP #ADP #Givosiran #Hematology #HemeOnc #MedEd #HemeHub

🩸 HemeHub is honored to have Spero Cataland, MD, as part of our Scientific Advisory Board. Dr. Cataland is a hematologist, Professor in the Division of Hematology, and Director of Classical Hematology at The Ohio State University (@OSUCCC_James). His clinical expertise includes platelet disorders, bleeding and clotting disorders, hemophilia, and von Willebrand disease. Dr. Cataland's research focuses on rare blood disorders, including TTP and aHUS. His work also includes international clinical trials and publications in prominent medical journals, including The New England Journal of Medicine, Blood, and the Journal of Thrombosis and Haemostasis. We are proud to have his expertise and leadership helping shape HemeHub’s commitment to advancing hematology education. 🌐 Learn more: hemehub.org #HemeHub #Hematology #BloodDisorders #ClassicalHematology #MedicalEducation #ClinicalResearch

🩸 Looking ahead to 2027! Our upcoming live webinar schedule is now available on our website! Explore the topics and discussions planned for the year ahead. 🌐 Learn more: hemehub.org/live-webinars #HemeHub #Hematology #HemeOnc #MedEd

🩸 Happening in two weeks! ⮕ Register: hemehub.org/live-webinars ⮕ Submit your cases: hemehub.org/case-submission #HemeHub #Hematology #ITP #RefractoryITP #ImmuneThrombocytopenia #HemeOnc @LombardiCancer @MedStarHealth @GUMedicine @UTSWMedCenter @UTSWHemeOnc

🎯Today’s questions! Swipe to see the answers and explanations! #HemeHub #Hematology #HemeOnc #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hepatocytes #MedEd #EPP #Porphyria #Afamelanotide #Bitopertin #GlyT1

🩸 Facts about Acute Hepatic Porphyria: Givosiran-associated pancreatitis and postmarketing safety signals, hemin treatment and associated risks, ALAS1 suppression, breakthrough attacks during givosiran therapy, and hepatocellular carcinoma risk and surveillance recommendations. #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hemin #Hematology #HemeOnc #MedEd #HemeHub

🩸 Schedule Update for HemeHub’s Post-ASH 2026 Live Webinar Series! Our Myeloma session will now take place on December 23, while the Leukemia, Lymphoma, and Classical Hematology sessions remain scheduled for December 21. 🔗 Register: hemehub.org/live-webinars #HemeHub #ASH2026 #PostASH2026 #Hematology #HematologyOncology #Myeloma #Leukemia #Lymphoma

🚀 Stay connected with HemeHub and more through the ClinEdPulse app! Available for download on: ⮕ App Store: apps.apple.com/us/app/clined… ⮕ Google Play: play.google.com/store/apps/d… 🌐 Explore more: hemehub.org #HemeHub #ClinEdPulse #MedEd #EndoExpertHub #OncExpertHub

🔎🌟Today’s questions! Swipe to see the answers and explanations! #HemeHub #Hematology #HemeOnc #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hepatocytes #MedEd

🩸Facts about Acute Hepatic Porphyria: Hyperhomocysteinemia during givosiran treatment, vitamin B6 supplementation, and givosiran-associated pancreatitis, including safety signals and time-to-onset. #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedEd #HemeHub

🌟 Looking forward to our Post-ASH 2026 Updates live webinar series on December 21! Join HemeHub for expert perspectives on the latest research and advances in hematology. 🌐 Register today: hemehub.org/live-webinars #HemeHub #ASH2026 #ASH26 #MedEd #Myeloma #Leukemia #Lymphoma #ClassicalHematology

🩸 Join us on November 6 for a discussion on Refractory Immune Thrombocytopenia with Catherine M. Broome, MD, and Taha Bat, MD! ⮕ Register: hemehub.org/live-webinars ⮕ Submit your cases: hemehub.org/case-submission #HemeHub #Hematology #ITP #RefractoryITP #ImmuneThrombocytopenia #HemeOnc @LombardiCancer @MedStarHealth @GUMedicine @UTSWMedCenter @UTSWHemeOnc

💡🚀Today’s questions! Swipe to see the answers and explanations! #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedicalEducation #MedEd #HemeHub

🩸 Facts about Acute Hepatic Porphyria: Givosiran treatment, long-term outcomes, common side effects, liver enzyme elevations, and hyperhomocysteinemia. #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedicalEducation #MedEd #HemeHub

🚀💡Today’s questions! Swipe to see the answers and explanations! #HemeHub #Hematology #HemeOnc #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hyperhomocysteinemia #VitaminB6 #MedEd

🩸 Facts about Acute Hepatic Porphyria: Heme synthesis, the role of the liver in AHP, how givosiran works, and its effectiveness in reducing acute attacks. #AHP #AcuteHepaticPorphyria #Porphyria #Givosiran #Hematology #HemeOnc #MedicalEducation #MedEd #HemeHub

🩸 Don’t miss our upcoming discussion on Refractory Immune Thrombocytopenia with Catherine M. Broome, MD, and Taha Bat, MD! ⮕ Register: hemehub.org/live-webinars ⮕ Submit your cases: hemehub.org/case-submission #HemeHub #Hematology #ITP #RefractoryITP #ImmuneThrombocytopenia #HemeOnc @LombardiCancer @MedStarHealth @GUMedicine @UTSWMedCenter @UTSWHemeOnc

🩸 We’re grateful to everyone who helped make the HemeHub Hematology Summit possible! Thank you to @TexasOncology and our Strategic Academic Partner, UTSW Harold C. Simmons Comprehensive Cancer Center (@utswcancer), for their support. We also extend our appreciation to the panel moderators, speakers and volunteers for their time, expertise, and contributions throughout the program. And most importantly, thank you to everyone who joined us. It was a pleasure to bring the hematology community together for a day of education, discussion, and connection! 🌐 Explore more: hemehub.org #HemeHub #HemeOnc #HematologySummit